Skip to main content

RxLightning Debuts Revolutionary MedAccess Ecosystem

By: Newsfile

New Albany, Indiana--(Newsfile Corp. - November 17, 2022) - Health tech start-up RxLightning today debuted its MedAccess Ecosystem, a first-of-its-kind platform that connects all stakeholders across the complex, disconnected universe that is specialty medication access in America and provides never-before realized visibility into the patient journey for the entire ecosystem of specialty pharmacy care.

To view the full announcement, including downloadable images, bios, and more, click here.

Key Takeaways:

  • New MedAccess Ecosystem, created and powered by RxLightning's digital platform, enables specialty therapy enrollment within a single day
  • Platform provides a single source of truth for all stakeholders, from prescribers to payors to pharmacy field representatives
  • Solution acts as a patient journey tracker, allowing everyone visibility into the process and creating a world where every patient gets accelerated access to life-saving therapies

Cannot view this image? Visit: https://images.newsfilecorp.com/files/7294/144644_figure1_550.jpg

Click image above to view full announcement.


About RxLightning

Founded in New Albany, Indiana in 2020, RxLightning enables physicians to accelerate patient access to their preferred specialty therapies. The RxLightning MedAccess platform was designed for physicians and their clinical team to re-imagine the entire specialty medication experience without paper forms or fax machines. The single platform comprehensively supports over 1,200 specialty medications across all therapeutic specialties. By automating the entire patient onboarding processes, it eliminates many of the prescribing burdens to increase patient conversion and decrease time to fill. 

With RxLightning, access to life-enhancing and life-saving medications is measured in hours, not days or weeks. Learn more at rxlightning.com.

Contacts:

Kriste Goad
(615)440-9049
kg@growwithfuoco.com

Source: RxLightning

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/144644

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.